US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Ofirmev

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0800-2017
Class II · Moderate risk Terminated

NOVA PeriCapsular injection all strengths

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0799-2017
Class II · Moderate risk Terminated

RECK PeriCapsular injection all strengths

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0798-2017
Class II · Moderate risk Terminated

Nalbuphine all strengths

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0797-2017
Class II · Moderate risk Terminated

Lidocaine all strengths

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0796-2017
Class II · Moderate risk Terminated

Edex

Reason Lack of Assurance of Sterility: Defective container resulting in the lack of sterility assurance. ok thanks

Endo Pharmaceuticals, Inc. NDC 52244-010-02 D-0512-2017
Class II · Moderate risk Terminated

Potassium PHOSphate in 0.5% Dextrose

Reason Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.

Pharmedium Services, LLC NDC 61553-0299-48 D-0908-2017
Class II · Moderate risk Terminated

Dorama-Neo

Reason Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Sato Pharmaceutical Inc. NDC 49873-020-01 D-0856-2017
Class II · Moderate risk Terminated

Sato Clear

Reason Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Sato Pharmaceutical Inc. NDC 49873-044-01 D-0855-2017
Class II · Moderate risk Terminated

Optic Splash

Reason Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Sato Pharmaceutical Inc. NDC 49873-501-01 D-0854-2017
Class II · Moderate risk Terminated

HealthA2Z CHEWABLE Aspirin

Reason cGMP deviations - presence of rubber particles found loose in the bulk product.

Allegiant Health D-0500-2017
Class II · Moderate risk Terminated

Famciclovir tablets

Reason Failed impurities/ degradation specifications: Product was above specification for unknown impurities.

AVKARE Inc. NDC 50268-307-13 D-0610-2017
Class II · Moderate risk Terminated

Kojic Acid 8%/Azelaic Acid 15% Cream

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0602-2017
Class II · Moderate risk Terminated

Intimate Bleaching Cream

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0601-2017
Class II · Moderate risk Terminated

Gentle Supreme Bleaching Cream

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0600-2017
Class II · Moderate risk Terminated

Custom Lightening/Brightening Cream

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0599-2017
Class II · Moderate risk Terminated

Sulfur 5% Cream

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0598-2017
Class II · Moderate risk Terminated

Metronidazole 1% Gel

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0595-2017